Physician profile
Donald Rubenstein
NPI 1912966276
$8,351.47
in general payments reported to CMS, 2019-2025
37 companies · $859 in 2025
The $859 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,191 · 2020: $543 · 2021: $693 · 2022: $1,639 · 2023: $1,327 · 2024: $1,100 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,191.05 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Novartis Pharmaceuticals Corporation | $1,324.48 | 2019-2025 | |
| Pfizer INC. | $808.54 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $603.60 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $478.99 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $364.17 | 2019-2025 | Cardiomems |
| Amgen INC. | $325.74 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $280.85 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $235.73 | 2019-2022 | |
| Novo Nordisk INC | $147.65 | 2021-2024 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $127.62 | 2019-2024 | |
| Heartflow, INC. | $125.10 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.97 | 2022-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $114.85 | 2023-2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $103.38 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $102.17 | 2020-2025 | Farxiga |
| Lundbeck LLC | $100.76 | 2019-2021 | |
| Irhythm Technologies, INC. | $86.01 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.65 | 2021-2024 | Lifevest |
| Philips North America LLC | $76.28 | 2022-2025 | Extended Holter, Mcot, (Ck4) Mcot |
| Cvrx, INC. | $75.45 | 2022-2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $58.79 | 2022-2024 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $57.70 | 2023-2024 | Inpefa |
| Itamar Medical INC | $55.52 | 2022 | |
| Alnylam Pharmaceuticals INC. | $48.31 | 2022-2025 | Amvuttra |
| Altathera Pharmaceuticals LLC | $43.40 | 2024-2025 | Sotalol Hydrochloride |
| Kowa Pharmaceuticals America, INC. | $41.55 | 2019-2022 | |
| Inari Medical, INC. | $25.50 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Arbor Pharmaceuticals, INC. | $23.76 | 2019 | |
| Amryt Pharma Holdings LTD | $19.19 | 2020 | |
| Bridgebio Pharma, INC. | $19.00 | 2025 | Attruby |
| Scpharmaceuticals INC. | $17.81 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $16.40 | 2023 | Arcalyst |
| Vifor Pharma, INC. | $15.98 | 2023 | Veltassa |
| Kiniksa Pharmaceuticals International, Plc | $15.94 | 2024 | Arcalyst |
| Acarix USA INC. | $13.21 | 2024 | Cadscor System |
| Welch Allyn | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.